Published in Antimicrob Agents Chemother on February 01, 1987
Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev (2008) 17.77
Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2007) 7.84
Agents that increase the permeability of the outer membrane. Microbiol Rev (1992) 7.52
Polymyxins revisited. Clin Microbiol Rev (2008) 3.16
Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob Agents Chemother (2000) 3.06
Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta (2008) 2.73
Spontaneous pmrA mutants of Salmonella typhimurium LT2 define a new two-component regulatory system with a possible role in virulence. J Bacteriol (1993) 2.46
In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother (1999) 2.10
Salt-resistant alpha-helical cationic antimicrobial peptides. Antimicrob Agents Chemother (1999) 1.78
Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect. Antimicrob Agents Chemother (1993) 1.57
Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification. Antimicrob Agents Chemother (1994) 1.51
Effect of small cationic leukocyte peptides (defensins) on the permeability barrier of the outer membrane. Infect Immun (1988) 1.27
Interaction of aminoglycosides with the outer membranes and purified lipopolysaccharide and OmpF porin of Escherichia coli. Antimicrob Agents Chemother (1991) 1.22
Enhanced binding of polycationic antibiotics to lipopolysaccharide from an aminoglycoside-supersusceptible, tolA mutant strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1988) 1.17
Mechanisms of antibacterial action of tachyplesins and polyphemusins, a group of antimicrobial peptides isolated from horseshoe crab hemocytes. Antimicrob Agents Chemother (1992) 1.10
Pseudomonas aeruginosa outer membrane protein OprH: expression from the cloned gene and function in EDTA and gentamicin resistance. J Bacteriol (1991) 1.09
Escherichia coli susceptible to glycopeptide antibiotics. Antimicrob Agents Chemother (1989) 1.05
Irreproducible and uninterpretable Polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol (2013) 1.02
Outer membrane protein I of Pseudomonas aeruginosa is a target of cationic antimicrobial peptide/protein. J Biol Chem (2010) 0.99
Polycation binding to isolated lipopolysaccharide from antibiotic-hypersusceptible mutant strains of Escherichia coli. Antimicrob Agents Chemother (1988) 0.98
Outer membrane lipoprotein Lpp is Gram-negative bacterial cell surface receptor for cationic antimicrobial peptides. J Biol Chem (2011) 0.94
Aminoglycosides modify the in vitro metachromatic reaction and murine generalized Shwartzman phenomenon induced by Salmonella minnesota R595 lipopolysaccharide. Antimicrob Agents Chemother (1991) 0.83
Cooperation of the multidrug efflux pump and lipopolysaccharides in the intrinsic antibiotic resistance of Salmonella enterica serovar Typhimurium. J Antimicrob Chemother (2013) 0.80
Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System. Antimicrob Agents Chemother (2015) 0.77
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A new method for the extraction of R lipopolysaccharides. Eur J Biochem (1969) 22.41
Molecular basis of bacterial outer membrane permeability. Microbiol Rev (1985) 17.75
Outer membrane of Salmonella typhimurium. Transmembrane diffusion of some hydrophobic substances. Biochim Biophys Acta (1976) 7.44
The barrier function of the gram-negative envelope. Ann N Y Acad Sci (1974) 6.08
Structural investigations on the 2-keto-3-deoxyoctonate region of lipopolysaccharides. Eur J Biochem (1970) 4.14
Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1981) 3.95
A highly sensitive periodic acid-silver stain for 1,2-diol groups of glycoproteins and polysaccharides in polyacrylamide gels. Anal Biochem (1982) 3.82
Interaction of divalent cations and polymyxin B with lipopolysaccharide. Biochemistry (1979) 3.58
Polycations sensitize enteric bacteria to antibiotics. Antimicrob Agents Chemother (1983) 3.33
Polycations as outer membrane-disorganizing agents. Antimicrob Agents Chemother (1983) 3.06
Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett (1981) 2.91
Action of polymyxin B on bacterial membranes: morphological changes in the cytoplasm and in the outer membrane of Salmonella typhimurium and Escherichia coli B. Antimicrob Agents Chemother (1975) 2.69
The relationship between the O-antigenic lipopolysaccharides and serological specificity in strains of Pseudomonas aeruginosa of different O-serotypes. J Gen Microbiol (1973) 2.61
High-molecular-weight components in lipopolysaccharides of Salmonella typhimurium, Salmonella minnesota, and Escherichia coli. J Bacteriol (1985) 2.46
Increased outer membrane resistance to ethylenediaminetetraacetate and cations in novel lipid A mutants. J Bacteriol (1981) 2.19
Action of polymyxin B on bacterial membranes. 1. Binding to the O-antigenic lipopolysaccharide of Salmonella typhimurium. Z Naturforsch C (1974) 2.06
Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa. J Bacteriol (1985) 1.90
Quantitation of metal cations bound to membranes and extracted lipopolysaccharide of Escherichia coli. Biochemistry (1983) 1.87
Decreased binding of polymyxin by polymyxin-resistant mutants of Salmonella typhimurium. J Bacteriol (1979) 1.82
Cell wall alterations of gram-negative bacteria by aminoglycoside antibiotics. Antimicrob Agents Chemother (1974) 1.81
Outer membrane permeability barrier disruption by polymyxin in polymyxin-susceptible and -resistant Salmonella typhimurium. Antimicrob Agents Chemother (1981) 1.79
Susceptibility of gram-negative bacteria to polymyxin B nonapeptide. Antimicrob Agents Chemother (1984) 1.67
Binding of polymyxin B nonapeptide to gram-negative bacteria. Antimicrob Agents Chemother (1985) 1.67
Chemical structure of the lipid A component of the lipopolysaccharide from a Proteus mirabilis Re-mutant. Eur J Biochem (1983) 1.54
Action of polymyxin B on bacterial membranes. Binding capacities for polymyxin B of inner and outer membranes isolated from Salmonella typhimurium G30. Arch Microbiol (1976) 1.52
Structure and metal-binding properties of lipopolysaccharides from heptoseless mutants of Escherichia coli studied by 13C and 31P nuclear magnetic resonance. J Biol Chem (1983) 1.44
EM49: a new polypeptide antibiotic active against cell membranes. Ann N Y Acad Sci (1974) 1.21
Physical properties of defined lipopolysaccharide salts. Biochemistry (1983) 1.12
Disruption of Escherichia coli outer membranes by EM 49. A new membrane active peptide. Biochemistry (1976) 1.11
A cationic electron spin resonance probe used to analyze cation interactions with lipopolysaccharide. Biochem Biophys Res Commun (1981) 1.03
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science (1997) 9.73
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature (1996) 8.37
Discovering high-affinity ligands for proteins: SAR by NMR. Science (1996) 7.10
Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature (1997) 4.55
Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate. Nature (1994) 4.49
14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell (2000) 4.05
Structural basis for the inhibition of caspase-3 by XIAP. Cell (2001) 3.91
Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature (2001) 3.22
'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737. Oncogene (2006) 3.10
NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature (1997) 3.04
Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci (2000) 3.00
Solution structure of the antiapoptotic protein bcl-2. Proc Natl Acad Sci U S A (2001) 2.60
Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature (1995) 2.59
High-molecular-weight components in lipopolysaccharides of Salmonella typhimurium, Salmonella minnesota, and Escherichia coli. J Bacteriol (1985) 2.46
Heterogeneity of lipopolysaccharides from Pseudomonas aeruginosa: analysis of lipopolysaccharide chain length. J Bacteriol (1988) 2.35
A general method for assigning NMR spectra of denatured proteins using 3D HC(CO)NH-TOCSY triple resonance experiments. J Biomol NMR (1993) 2.35
NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Nature (1999) 2.18
Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL. Mol Cell Biol (1997) 2.15
A computer-based protocol for semiautomated assignments and 3D structure determination of proteins. J Biomol NMR (1994) 2.14
The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. A new peroxisomal enzyme. J Biol Chem (1973) 2.10
Occurrence of a common lipopolysaccharide antigen in standard and clinical strains of Pseudomonas aeruginosa. J Clin Microbiol (1989) 2.07
Model for mammalian metallothionein structure. Proc Natl Acad Sci U S A (1983) 1.91
Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa. J Bacteriol (1985) 1.90
NMR structure and mutagenesis of the third Bir domain of the inhibitor of apoptosis protein XIAP. J Biol Chem (2000) 1.88
Quantitation of metal cations bound to membranes and extracted lipopolysaccharide of Escherichia coli. Biochemistry (1983) 1.87
Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J (1997) 1.83
Solution structure of an rRNA methyltransferase (ErmAM) that confers macrolide-lincosamide-streptogramin antibiotic resistance. Nat Struct Biol (1997) 1.82
NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc Natl Acad Sci U S A (2000) 1.75
Solution structure of a pleckstrin-homology domain. Nature (1994) 1.68
NMR structure and mutagenesis of the N-terminal Dbl homology domain of the nucleotide exchange factor Trio. Cell (1998) 1.67
NMR structure and mutagenesis of the FADD (Mort1) death-effector domain. Nature (1998) 1.65
Heteronuclear three-dimensional NMR spectroscopy of the inflammatory protein C5a. Biochemistry (1989) 1.63
Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms. EMBO J (1999) 1.62
Structural characterization of the FK506 binding protein unfolded in urea and guanidine hydrochloride. J Mol Biol (1994) 1.58
Side chain and backbone assignments in isotopically labeled proteins from two heteronuclear triple resonance experiments. FEBS Lett (1992) 1.56
Structural characterization of the interaction between a pleckstrin homology domain and phosphatidylinositol 4,5-bisphosphate. Biochemistry (1995) 1.53
Analysis of a common-antigen lipopolysaccharide from Pseudomonas aeruginosa. J Bacteriol (1989) 1.53
Solution structure of the cyclosporin A/cyclophilin complex by NMR. Nature (1993) 1.44
Structure and metal-binding properties of lipopolysaccharides from heptoseless mutants of Escherichia coli studied by 13C and 31P nuclear magnetic resonance. J Biol Chem (1983) 1.44
NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein. J Med Chem (1997) 1.41
Privileged molecules for protein binding identified from NMR-based screening. J Med Chem (2000) 1.40
Characterization of lipopolysaccharide from a heptoseless mutant of Escherichia coli by carbon 13 nuclear magnetic resonance. J Biol Chem (1983) 1.37
Regulation of flagellar morphogenesis by temperature: involvement of the bacterial cell surface in the synthesis of flagellin and the flagellum. J Bacteriol (1973) 1.34
Discovering high-affinity ligands for proteins. Science (1997) 1.33
Physical properties of short- and long-O-antigen-containing fractions of lipopolysaccharide from Escherichia coli 0111:B4. J Bacteriol (1986) 1.30
Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nat Struct Biol (1996) 1.25
Lipopolysaccharide tightly bound to porin monomers and trimers from Escherichia coli K-12. J Bacteriol (1987) 1.24
Phosphatidylinositol 4,5-bisphosphate binding to the pleckstrin homology domain of phospholipase C-delta1 enhances enzyme activity. J Biol Chem (1996) 1.23
Relationship of growth temperature and thermotropic lipid phase changes in cytoplasmic and outer membranes from Escherichia coli K12. Biochim Biophys Acta (1979) 1.21
Solution structure of the ets domain of Fli-1 when bound to DNA. Nat Struct Biol (1994) 1.20
An approach for high-throughput structure determination of proteins by NMR spectroscopy. J Biomol NMR (2000) 1.18
Equilibrium denaturation of recombinant human FK binding protein in urea. Biochemistry (1993) 1.18
Enhanced binding of polycationic antibiotics to lipopolysaccharide from an aminoglycoside-supersusceptible, tolA mutant strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1988) 1.17
High-throughput nuclear magnetic resonance-based screening. J Med Chem (1999) 1.15
Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Proc Natl Acad Sci U S A (1996) 1.14
Physical properties of defined lipopolysaccharide salts. Biochemistry (1983) 1.12
Effects of pH on bacterial porin function. Biochemistry (1992) 1.11
NMR-based screening in drug discovery. Q Rev Biophys (1999) 1.10
Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivo. Mol Cell Biol (1997) 1.08
NMR studies of the anti-apoptotic protein Bcl-xL in micelles. Biochemistry (2000) 1.07
Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria. Antimicrob Agents Chemother (1990) 1.06
Dephosphorylation of the lipid A moiety of Escherichia coli lipopolysaccharide by mouse macrophages. Infect Immun (1987) 1.04
A cationic electron spin resonance probe used to analyze cation interactions with lipopolysaccharide. Biochem Biophys Res Commun (1981) 1.03
Novel inhibitors of Erm methyltransferases from NMR and parallel synthesis. J Med Chem (1999) 1.01
Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc. J Biol Chem (1995) 1.00
Backbone dynamics of the C-terminal domain of Escherichia coli topoisomerase I in the absence and presence of single-stranded DNA. Biochemistry (1996) 1.00
Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein. J Med Chem (1999) 0.99
Solution structure of the C-terminal single-stranded DNA-binding domain of Escherichia coli topoisomerase I. Biochemistry (1995) 0.99
A practical method for uniform isotopic labeling of recombinant proteins in mammalian cells. Biochemistry (1992) 0.98
Polycation binding to isolated lipopolysaccharide from antibiotic-hypersusceptible mutant strains of Escherichia coli. Antimicrob Agents Chemother (1988) 0.98
Solution structure and function of a conserved protein SP14.3 encoded by an essential Streptococcus pneumoniae gene. J Mol Biol (2001) 0.97
A 4D HCCH-TOCSY experiment for assigning the side chain 1H and 13C resonances of proteins. J Biomol NMR (1992) 0.96
Changes in the NMR-derived motional parameters of the insulin receptor substrate 1 phosphotyrosine binding domain upon binding to an interleukin 4 receptor phosphopeptide. Biochemistry (1997) 0.96
Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor. Proc Natl Acad Sci U S A (1995) 0.95
Use of deuterium labeling in NMR: overcoming a sizeable problem. Structure (1996) 0.95
Solution structure of the cytohesin-1 (B2-1) Sec7 domain and its interaction with the GTPase ADP ribosylation factor 1. Proc Natl Acad Sci U S A (1998) 0.94
RNAi-based screening of the human kinome identifies Akt-cooperating kinases: a new approach to designing efficacious multitargeted kinase inhibitors. Oncogene (2006) 0.93
pH titration of the histidine residues of cyclophilin and FK506 binding protein in the absence and presence of immunosuppressant ligands. Biochim Biophys Acta (1994) 0.93
Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: evidence for flexible DNA-binding regions. Biochemistry (1996) 0.93
Acid pH decreases OmpF and OmpC channel size in vivo. Biochem Biophys Res Commun (1992) 0.92
Dynamic properties of membrane proteins: reversible insertion into membrane vesicles of a colicin E1 channel-forming peptide. Proc Natl Acad Sci U S A (1988) 0.92
Channel-closing activity of porins from Escherichia coli in bilayer lipid membranes. Biochim Biophys Acta (1986) 0.92
A pH titration study on the ionic bridging within lipopolysaccharide aggregates. Biochim Biophys Acta (1985) 0.91
Determination of the anomeric specificity of the Escherichia coli CTP:CMP-3-deoxy-D-manno-octulosonate cytidylyltransferase by 13C NMR spectroscopy. J Biol Chem (1985) 0.91
Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator. Biochemistry (1994) 0.91
Use of electron spin resonance to study Bacillus megaterium spore membranes. Biochem Biophys Res Commun (1979) 0.90
The secondary structure of the ets domain of human Fli-1 resembles that of the helix-turn-helix DNA-binding motif of the Escherichia coli catabolite gene activator protein. Proc Natl Acad Sci U S A (1994) 0.89
NMR studies of [U-13C]cyclosporin A bound to human cyclophilin B. FEBS Lett (1991) 0.88
Three-dimensional structures of proteins involved in programmed cell death. J Mol Biol (1997) 0.88
Conformation of two non-immunosuppressive FK506 analogs when bound to FKBP by isotope-filtered NMR. FEBS Lett (1992) 0.87
Anesthetic steroid mobility in model membrane preparations as examined by high-resolution 1H and 2H NMR spectroscopy. J Med Chem (1991) 0.87
31P and 13C NMR studies of oxygen transfer during catalysis by 3-deoxy-D-manno-octulosonate cytidylyltransferase from Escherichia coli. J Biol Chem (1987) 0.87
Common antigen lipopolysaccharide from Pseudomonas aeruginosa AK1401 as a receptor for bacteriophage A7. J Bacteriol (1992) 0.86
Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR. Biochemistry (1993) 0.86